CCL18 and neoplasm: Still, it is worth mentioning that CCL18, the second ligand for human CCR8, is strongly expressed in patients with solid tumors and reported to promote tumor progression by different means, including Treg cell and type-2 macrophage differentiation as well as mobilization of tumor cells (reviewed in [123].